In recent trading session, Impact BioMedical Inc (AMEX:IBO) saw 1.0 million shares changing hands at last check today with its beta currently measuring 0. Company’s recent per share price level of $0.50 trading at -$0.07 or -13.00% at last check today assigns it a market valuation of $5.70M. That most recent trading price of IBO’s stock is at a discount of -1134.0% from its 52-week high price of $6.17 and is indicating a discount of -2.0% from its 52-week low price of $0.51. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 23.07 million shares which gives us an average trading volume of 3.81 million if we extend that period to 3-months.

Impact BioMedical Inc (AMEX:IBO) trade information

Upright in the red during last session for losing -13.00%, in the last five days IBO remained trading in the red while hitting it’s week-highest on Friday, 03/28/25 when the stock touched $0.50 price level, adding 77.78% to its value on the day. Impact BioMedical Inc’s shares saw a change of -65.80% in year-to-date performance and have moved -78.25% in past 5-day. Impact BioMedical Inc (AMEX:IBO) showed a performance of -57.98% in past 30-days. Number of shares sold short was 9001.0 shares which calculate 0.3 days to cover the short interests.

Impact BioMedical Inc (AMEX:IBO)’s Major holders

Insiders are in possession of 55.16% of company’s total shares while institution are holding 1.89 percent of that, with stock having share float percentage of 4.22%. Investors also watch the number of corporate investors in a company very closely, which is 1.89% institutions for Impact BioMedical Inc that are currently holding shares of the company.

On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024, the former fund manager was holding 94.02 shares of worth $46182.0 or 0.78% of the total outstanding shares. The later fund manager was in possession of 31.61 shares on Dec 31, 2024, making its stake of worth around $15525.0 in the company or a holder of 0.26% of company’s stock.